mbq 167 MBQ-167-91化工仪器网

生产地：品牌：MedChemExpress （MCE）

移动电话：18019480960公司传真：86-021-53700325

更新时间：2019-07-02

MedChemExpress (MCE) 专注于为全球科学家提供高品质的生物活性小分子化合物，化合物库及各类试剂盒，总部位于美国新泽西。
 MedChemExpress (MCE) 产品作用于 20 多个热门信号通路及研究领域的300多个细分靶点，拥有 10000 特异性抑制剂、激动剂，以及 30 活性化合物筛选库；
 我们坚持对所有产品进行严格质检，确保产品的高品质和高纯度；
 MedChemExpress (MCE) 产品已被全球数万名科学家信赖，并被大量Top文献和Patent引用；
 我们拥有专业的技术团队追踪全球前沿科技进展，不断丰富各个靶点的特异性产品，坚持做 您身边的抑制剂大师 ；
 MedChemExpress (MCE) 与全球众多知名药企和科研机构保持深度合作；
 大量产品有中国库存，工作日 16:00 前订单确保当日发货，次日送达。
MCE 中国：www.MedChemExpress.cn

Hotline: 400-820-3792
Tel: 021-58955995
Email: sales@MedChemExpress.cn
Tech Support: 021-58950656

产品活性：MBQ-167 是 Ras 相关的 C3 型肉毒素底物 (Rac) 和细胞分裂周期蛋白 (Cdc42) 的双抑制剂，其对 Rac 1/2/3 的 IC50 值为 103 nM， 对 Cdc42 的 IC50 值为 78 nM。

研究领域：GPCR/G Protein | Cell Cycle/DNA Damage

作用靶点：Ras | CDK

In Vitro: MBQ-167 (≥100 nM) induces a loss of polarity in metastatic breast cancer cells. Treatment with 500 nM MBQ-167 for 24 h results in ~95% cell rounding and detachment from the substratum in metastatic MDA-MB-231 cells. Moreover, MBQ-167 induces this phenotype in multiple mesenchymal cancer cell types including GFP-HER2-BM, MDA-MB-468, and Hs578t human breast cancer cells, as well as Mia-PaCa-2 pancreatic cancer cells, SKOV3 ovarian cancer cells, AGS and NCI-N87 gastric cancer cells, and SH-SY5Y neuroblastoma cells. Following treatment with 250 nM MBQ-167 for 24 h, the attached population of MDA-MB-231 cells demonstrate a ~25% decrease in Rac activation while the detached cells are more responsive with a ~75% decrease. At earlier times (6h), treatment with 250 or 500 nM MBQ-167, induce a inhibition in Rac activity in the attached cell population, while the detached population demonstrate a ~40-50% inhibition.

In Vivo: MBQ-167-treated mice demonstrate a statistically significant reduction in tumor growth. At sacrifice, 1.0 mg/kg BW of MBQ-167 results in a ~80% reduction in tumor growth, and the 10 mg/kg BW MBQ-167 treatment results in ~95% reduction in tumor growth. Since EHop-016 only exerts ~40% reduction of tumor growth at 10 mg/kg BW, MBQ-167 is 10X more effective than EHop-016. MBQ-167 treated mice demonstrate similar doubling times for both treatments (10 and 11 days).

相关产品：Kinase Inhibitor Library | GPCR/G Protein Compound Library | Anti-Cancer Compound Library | Cell Cycle/DNA Damage Compound Library | Bioactive Compound Library Plus | Palbociclib | Abemaciclib methanesulfonate | Ribociclib | Dinaciclib | THZ531 | ARS-1620 | THZ1 | Seliciclib | NVP-2 | Ro-3306 | Flavopiridol | ARS-853 | CYC065 | Atuveciclib Racemate | NSC 23766 trihydrochloride | AZD4573 | ML141 | GSK 3 Inhibitor IX | Pan-RAS-IN-1 | SNS-032 | SB1317 | Kenpaullone | Rhosin hydrochloride | CDK9-IN-2 | Salirasib | AZD-5438